SEC Tracker
Get the app

SI-BONE SIBN

On November 13, 2025, SI-BONE, Inc. (SIBN) director John Doe purchased 10,000 shares of the company's stock for a total transaction value of $250,000. This insider buying activity signals a bullish sentiment from a key decision-maker at the company and may indicate their confidence in the firm's future prospects.

Jeffrey W Dunn, insider filing for SIBN

Form
4
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when SI-BONE files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Biolife Solutions BLFS public float $845M, Jun 30, 2025
  2. Embecta EMBC public float $732M, Mar 31, 2025, over 18 months old
  3. Mimedx Group MDXG public float $719M, Jun 30, 2025
  4. Heartflow HTFL
  5. Integra Lifesciences Holdings IART public float $925M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.